Master Clinical Trial Agreements
Abbott Cardiovascular Systems (effective 3.17.2011 until amended)
Amgen Inc. (effective 8.18.2005 until amended)
Astellas Pharma Global Development, Inc. (effective 10.2.2014 through 10.2.2024)
AstraZeneca Pharmaceuticals LP (effective 2.19.2019 until amended (only for use by: DMC, SBU & UMU)
Biogen MA, Inc. (effective 4.16.2020 through 4.15.2027)
Boehringer Ingelheim Pharmaceuticals, Inc. (effective 1.3.2017 through 4.4.2023)
Boston Scientific Corporation (effective 2.18.2021-2.17.2026)
Edwards Lifesciences (effective 9.28.2018 until amended)
Genentech, Inc. (effective 5.31.2017 through 5.30.27)
Gilead Sciences, Inc. (effective through 5.21.2023)
Heron Therapeutics (effective 1.3.2020 until amended)
Lilly Research Labs (effective 3.11.2005 until amended)
Medtronic, Inc. (effective 3.2.2021 through 3.1.2026)
Merck Sharpe & Dohme (effective 5.15.2014 until amended)
Novartis Pharmaceuticals Corporation (effective through 8.31.2024)
Novo Nordisk, Inc. (effective 6.27.2019 through 2024)
Penumbra, Inc. (effective 2.4.2021 until amended)
Pharmaceutical Research Associates, Inc. (PRA) (effective 12.17.2020 through 12.16.2025)
Sanofi US Services, Inc. (effective 1.3.2013 through 1.2.2025)
Serono, Inc. (effective 7.1.2006 until amended)
Sunesis Pharmaceuticals (effective 5.2.2011 until amended)
UCB Biopharma SRL (effective 8.19.2013 until amended)
Vertex Pharma, Inc. (effective 10.28.2021 through 10.26.2026)
Warner Chilcott (effective 8.202011 until amended
Master Confidentiality Agreements
AbbVie (effective 8.31.2021 through 8.30.2026)
Amgen (effective 2.24.2023 through 2.23.2031)
AstraZeneca Pharmaceuticals LP/AstraZeneca LP (effective 1.22.2015 through 1.21.2025)
Bayer HealthCare Pharmaceuticals (effective 12.1.2020 through 11.30.2025)
Biogen MA, Inc. (effective 11.7.2018 through 11.6.2023)
Boehringer Ingelheim Pharmaceuticals, Inc. (effective 12.19.2015 through 12.18.2026)
Jansen Research Development (9.21.2021 through 9.20.2026)
Lilly USA (effective 2.22.2023 until amended)
Merk Sharp & Dohme Corp. (effective 07.05.2022 through 07.05.2027)
MicroVention, Inc. (effective 9.13.2019 through 9.12.2024) (only for use by: BU, DMC, UMU)
Novartis Pharmaceuticals, Corporation (effective 7.1.2019 through 6.30.2024)
Pharmaceutical Research Associates (effective 7.30.2019 through 7.29.2029)
PPD Investigator Services, LLC (Updated effective through 9.5.2023)